On this week's COVID-19 update, Dr. Bishop dives into all things Omicron. What is it? How do variants happen? What do we know? What don't we know? And what does this all mean? Watch the update below and read on for a recap.
On this week's COVID-19 update, Dr. Bishop did a deep dive into how the Merck and Pfizer COVID pills function, touched on immunity from Regeneron, and provided an update on the vaccination process for children 5 to 11. Watch the video below or read on for our full recap.
In this week's COVID-19 update, Dr. Bishop discusses a couple of studies related to natural immunity and boosters, a few potential treatments for COVID, and more. Watch the full update below and read on for the recap.
This week, the FDA approved an emergency use authorization for Pfizer's vaccine for children ages 5 to 11. The CDC will meet next week to officially vote on their use in the United States. Ahead of the FDA meeting, Pfizer released a large amount of data from their trials. On this week's COVID-19 update, Dr. Bishop analyzed that data, including:
On this week's COVID-19 update, Dr. Bishop discussed what's happening with booster doses for Moderna and J&J and when they might be ready, data on getting COVID vaccines and flu shots at the same time, and the potential for mix-and-match COVID vaccinations.
The FDA's Vaccine Advisory Committee is meeting Thursday and Friday to discuss boosters for both Moderna and Johnson & Johnson. Ahead of the meeting, the FDA and the companies released data on their trials.
On this week's COVID-19 update, Dr. Bishop discussed new information regarding Long COVID, He answered questions such as:
On this week's COVID-19 update, Dr. Bishop discussed where we are in terms of the Delta variant wave, Pfizer's submission of vaccine data for kids 5 to 11, the timeline for Moderna and J&J boosters, and more.